FERMENTALG WKN: A1103M ISIN: FR0011271600 Kürzel: 1F6 Forum: Aktien Thema: Hauptdiskussion
0,3475 EUR
±0,00 %±0,0000
21. Dec, 12:59:58 Uhr,
Lang & Schwarz
Kommentare 136
Einfach_Ich,
10.02.2024 11:15 Uhr
0
Schon erstaunlich das sie nach dem Rücksetzer weiter steigt.
Vielleicht sehen wir bald 1 €.🤔
ElZorroBieroso,
06.02.2024 20:06 Uhr
0
The documents relating to the General Meeting provided to shareholders must be published on the Company's website, no longer twenty-one (21) days before the date of the General Meeting but only on the date of convocation.
The notice of availability of the preparatory documents for the general meeting will no longer be required.
The publication on the Company's website of the results of the votes and the minutes of the general meeting will no longer be required.
The Company will no longer be subject to the «say on pay» mechanism providing for the prior vote of shareholders on the executive remuneration policy, the subsequent vote on the remuneration report and the approval of individual executive remuneration.
The Corporation will no longer be held accountable for internal control or risk management.
The Company will no longer be subject to the provisions of Articles L. 823-19 and following of the French Commercial Code as regards audit committees, but may maintain this committee if it so wishes.
Indicative timetable for the transfer to Euronext Growth Paris
In the coming days, an application to delist the shares of Euronext Paris' Fermentalg and their concomitant admission to Euronext Growth Paris will be filed with Euronext Paris. Subject to the agreement of Euronext Paris, admission to Euronext Growth Paris will take place within a minimum period of two (2) months from the General Meeting that approved the Transfer, at the earliest on 2 April 2024, and within the limit of twelve (12) month following the date of the General Meeting.
The Company will be supported in its transfer project on Euronext Growth Paris by CIC Market Solutions as a listing sponsor.
Next publication: results of the 2023 financial year and
turnover of the 1st quarter 2024, 3 April 2024 (after the closing of the markets)
ElZorroBieroso,
06.02.2024 20:05 Uhr
0
In terms of periodic information:
The half-yearly report, including the half-yearly (and consolidated) financial statements and an activity report relating to these half-yearly financial statements, will be published within four months of the end of the first half of the Company's financial year, instead of the three-month period applicable to companies whose securities are admitted to trading on a regulated market.
The statutory auditors' review of the half-year accounts will be maintained, although no longer required.
Some information required under the management and corporate governance report will be reduced.
The Company will continue to prepare consolidated financial statements in accordance with IFRS accounting standards.
The Company will continue with the current publication of its quarterly financial information.
For ongoing information:
Euronext Growth Paris being a multilateral trading system, the Company would remain subject to the provisions applicable to permanent market information, and in particular to the provisions of the Regulation (EU) n°596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (" MAR"). Any company listed on Euronext Growth Paris must ensure the effective and complete dissemination of the so-called regulated information.
In addition, the officers of the Company and persons closely associated with them would remain subject to the obligation to report transactions in the Company's shares or debt instruments in accordance with section 19 of the MAR Regulation.
As regards the protection of minority shareholders:
Unless otherwise agreed, the protection of minority shareholders is ensured on Euronext Growth Paris by the mandatory public offer mechanism in the event of crossing, directly or indirectly, alone or in concert, the 50% threshold of the capital or voting rights.
Only crossings, up or down, of thresholds of 50% and 95% of the capital or voting rights are to be reported to the AMF and the Company, subject to crossings of statutory thresholds to be reported to the Company.
ElZorroBieroso,
06.02.2024 20:05 Uhr
0
Subject to the agreement of Euronext Paris, the listing of the company on Euronext Growth Paris will be carried out as part of an accelerated procedure for the admission to trading of the company's existing shares, without issuing new shares.
Reasons for the transfer
This project aims to enable the company Fermentalg S.A. to reduce the constraints associated with the regulated market Euronext Paris and the resources committed to meet them. Euronext Growth Paris offers a simplified operation, more adapted to the size, activity, market capitalization and needs of the Company, while allowing it to continue to benefit from the attractiveness of the financial markets.
Consequences of the transfer
In accordance with current regulations, the Company wishes to inform its shareholders of certain possible consequences of such a Transfer (non-exhaustive list):
ElZorroBieroso,
06.02.2024 20:05 Uhr
0
Heute im Newsletter
Libourne – February 6, 2024 – The General Assembly of Fermentalg (FALG), meeting on February 2, 2024, approved in accordance with the provisions of Article L.421-14 of the French Monetary and Financial Code, the proposed listing transfer of its securities on the regulated market Euronext Paris (Subfund C), to Euronext Growth Paris, and conferred all powers to the Board of Directors to implement this listing market transfer. The Board of Directors, which met on 5 February 2024, decided to implement this transfer.
ElZorroBieroso,
02.02.2024 12:58 Uhr
0
Die Zahlen sind allerdings mega.
https://www.finanznachrichten.de/nachrichten-2024-01/61237570-fermentalg-after-eur4m-in-sales-in-2023-fermentalg-kicks-off-2024-with-over-eur9m-in-contracts-and-orders-650.htm
90 Prozent des Ziels für 2024 schon erfüllt. Ich lege nochmal nach beim nächsten kleinen Dip Richtung 0,39.
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | Trading- und Aktien-Chat | ||
2 | News - InnoCan Pharma Aktie | ±0,00 % | |
3 | Vestas | ±0,00 % | |
4 | VALNEVA SE Hauptdiskussion | ±0,00 % | |
5 | AFC ENERGY Hauptdiskussion | ±0,00 % | |
6 | BRISTOL-MYERS Hauptdiskussion | +0,40 % | |
7 | Palantir | +0,85 % | |
8 | TESLA MOTORS Hauptdiskussion | +0,28 % | |
9 | ROCK TECH LITHIUM Hauptdiskussion | ±0,00 % | |
10 | BURBERRY Hauptdiskussion | ±0,00 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | News - InnoCan Pharma Aktie | ±0,00 % | |
2 | Vestas | ±0,00 % | |
3 | VALNEVA SE Hauptdiskussion | ±0,00 % | |
4 | AFC ENERGY Hauptdiskussion | ±0,00 % | |
5 | BRISTOL-MYERS Hauptdiskussion | +0,40 % | |
6 | Palantir | +0,85 % | |
7 | TESLA MOTORS Hauptdiskussion | +0,28 % | |
8 | ROCK TECH LITHIUM Hauptdiskussion | ±0,00 % | |
9 | BURBERRY Hauptdiskussion | ±0,00 % | |
10 | MICROSTRATEGY Hauptdiskussion | ±0,00 % | Alle Diskussionen |